Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Neonc Technologies, Inc

+1 (310) 663-7831
Website

Advertisement

Advertisement

8335 W Sunset Blvd Ste 241
Los Angeles, CA 90069
+1 (310) 663-7831
https://neonctech.com

Neonc Technologies, Inc is a cutting-edge technology company based in Los Angeles, California.

With its corporate headquarters located on Sunset Boulevard, Neonc Technologies is poised to revolutionize the industry with its innovative solutions.

Generated from the website

Also at this address

Red Granite Pictures

Bagel Mafia Inc

Moon River Media Inc

Brilliant Gems LLC

yelp logo
7 reviews

Find related places

Clinic

Clinic

Own this business?
Claim it
See a problem?

You might also like

Proteogenex

ProteoGenex Corporation is a privately held US company founded in Los Angeles in 2003. Headquarter in Culver City, California, along with a large state research laboratory in Moscow, Russia, with 35 employees, including 30 Molecular Biologists, Cell Biologists, Biochemists, Pathologists ( 15 PhDs, 5 MDs, 15 MSs ). ProteoGenex offers an access to the extensive Biorepository as well as to the exclusive custom designed human tissue-based research service, which is the company's largest and fastest growing business segment. Our unique broad Biobank is composed of well-defined and categorized clinical samples, including tissues, blood, serum, bone marrow, tissue microarrays, and etc. These samples are collected from a network of academic and professional clinical institutions under strict ethical standards. ProteoGenex collects biomaterials covering such disease targets as Oncology, Dermatology, Neurology, Immunology, Infectious diseases, Autoimmune and Metabolic disorders. Our products are derived from a variety of diseased human sources as well as from normal tissues and supported by pathology information and patient's clinical history documentation.

Eyenuk Inc

Eyenuk Inc is a leading healthcare technology company based in Woodland Hills, CA. They specialize in providing AI-powered solutions for professionals in the medical field, including physicians, optometrists, ophthalmologists, endocrinologists, diabetologists, nurses, educators, insurers, and payors. Their innovative AI Eye Screening technology is designed to detect and diagnose various eye diseases, such as age-related macular degeneration, diabetic retinopathy, and glaucoma. Eyenuk offers a range of products and services, including the EyeArt and Eyescreen Service, as well as retinal cameras. With a strong focus on clinical evidence and collaboration, Eyenuk is dedicated to improving eye healthcare through cutting-edge technology. Committed to regulatory compliance and privacy, Eyenuk has been independently audited for HIPAA privacy and security compliance. They offer opportunities for professionals to collaborate on AI research and clinical studies, as well as partner with the company. With a global presence, Eyenuk has offices in the Americas and Asia, serving customers worldwide. Their team of experienced professionals, including board members and clinical collaborators, work together to drive innovation and provide effective solutions for eye healthcare professionals. Stay updated with Eyenuk through their newsletter and benefit from their expertise in AI Eye Screening technology.Generated from the website
Eating places

Genervon Biopharmaceuticals

Genervon Biopharmaceuticals is a clinical-stage biopharmaceutical company based in Montebello, CA, dedicated to pioneering a new approach to drug development for complex neurological disorders. With a focus on multi-target drug discovery, Genervon has discovered a naturally occurring regulator of the human nervous system and developed a safe and well-tolerated peptide analog called GM6, which can penetrate the blood-brain barrier. GM6 has shown promising results in modulating biomarkers and defective pathways associated with neurodegenerative diseases, offering potential improvements in clinical outcomes for patients. With numerous worldwide patents, Genervon is currently planning late-stage clinical trials for GM6 in indications such as ALS, Parkinson's disease, Alzheimer's disease, and multiple sclerosis. Recognizing the urgent need for curative therapies, the company has dedicated the last two decades to research and development, employing a master regulatory approach to target the underlying pathophysiology and multiple pathways of neurodegenerative diseases and disorders. Genervon is actively seeking partnerships to advance GM6 from a development-stage drug candidate to a marketable therapy, providing much-needed help to the countless individuals affected by these debilitating conditions.Generated from the website
United States›California›Los Angeles›Neonc Technologies, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Partial Data by Foursquare.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell